BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28894229)

  • 1. VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastoma.
    Weng WC; Lin KH; Wu PY; Ho YH; Liu YL; Wang BJ; Chen CC; Lin YC; Liao YF; Lee WT; Hsu WM; Lee H
    Sci Rep; 2017 Sep; 7(1):11212. PubMed ID: 28894229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calreticulin Regulates VEGF-A in Neuroblastoma Cells.
    Weng WC; Lin KH; Wu PY; Lu YC; Weng YC; Wang BJ; Liao YF; Hsu WM; Lee WT; Lee H
    Mol Neurobiol; 2015 Aug; 52(1):758-70. PubMed ID: 25288151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma.
    Chang HH; Lee H; Hu MK; Tsao PN; Juan HF; Huang MC; Shih YY; Wang BJ; Jeng YM; Chang CL; Huang SF; Tsay YG; Hsieh FJ; Lin KH; Hsu WM; Liao YF
    Clin Cancer Res; 2010 Sep; 16(17):4411-20. PubMed ID: 20736329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calreticulin expression in neuroblastoma--a novel independent prognostic factor.
    Hsu WM; Hsieh FJ; Jeng YM; Kuo ML; Chen CN; Lai DM; Hsieh LJ; Wang BT; Tsao PN; Lee H; Lin MT; Lai HS; Chen WJ
    Ann Oncol; 2005 Feb; 16(2):314-21. PubMed ID: 15668290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.
    Lee AC; Shih YY; Zhou F; Chao TC; Lee H; Liao YF; Hsu WM; Hong JH
    J Mol Med (Berl); 2019 Mar; 97(3):325-339. PubMed ID: 30612140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
    Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
    J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
    Zins K; Kovatchki D; Lucas T; Abraham D
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
    Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
    Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
    Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
    Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
    Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.
    Ho WL; Chou CH; Jeng YM; Lu MY; Yang YL; Jou ST; Lin DT; Chang HH; Lin KH; Hsu WM; Huang MC
    Oncotarget; 2014 Dec; 5(23):12247-59. PubMed ID: 25362349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts.
    Liu S; Tian Y; Chlenski A; Yang Q; Zage P; Salwen HR; Crawford SE; Cohn SL
    Am J Pathol; 2005 Mar; 166(3):891-900. PubMed ID: 15743800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Ki-67, p53 and VEGF in pediatric neuroblastoma.
    Gheytanchi E; Mehrazma M; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(7):3065-70. PubMed ID: 24815448
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1229-E1238. PubMed ID: 29374092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts.
    Segerström L; Fuchs D; Bäckman U; Holmquist K; Christofferson R; Azarbayjani F
    Pediatr Res; 2006 Nov; 60(5):576-81. PubMed ID: 16988184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma.
    Amoroso F; Capece M; Rotondo A; Cangelosi D; Ferracin M; Franceschini A; Raffaghello L; Pistoia V; Varesio L; Adinolfi E
    Oncogene; 2015 Oct; 34(41):5240-51. PubMed ID: 25619831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer.
    Chen CN; Chang CC; Su TE; Hsu WM; Jeng YM; Ho MC; Hsieh FJ; Lee PH; Kuo ML; Lee H; Chang KJ
    Ann Surg Oncol; 2009 Feb; 16(2):524-33. PubMed ID: 19050968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells.
    Boyineni J; Tanpure S; Gnanamony M; Antony R; Fernández KS; Lin J; Pinson D; Gondi CS
    Int J Oncol; 2016 Oct; 49(4):1394-406. PubMed ID: 27498840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calreticulin regulates vascular endothelial growth factor-A mRNA stability in gastric cancer cells.
    Lee PC; Chiang JC; Chen CY; Chien YC; Chen WM; Huang CW; Weng WC; Chen CI; Lee PH; Chen CN; Lee H
    PLoS One; 2019; 14(11):e0225107. PubMed ID: 31725767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.